ArticleMolecular therapy. Nucleic acids2020
sTAM: An Online Tool for the Discovery of miRNA-Set Level Disease Biomarkers.
Article in Molecular therapy. Nucleic acids, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 4 citations in OpenAlex.
- XGBoost framework with feature selection for the prediction of RNA N5-methylcytosine sites.Molecular therapy : the journal of the American Society of Gene Therapy · 2023Article
- Article
- Y/X-Chromosome-Bearing Sperm Shows Elevated Ratio in the Left but Not the Right Testes in Healthy Mice.Life (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MicroRNAs (miRNAs) are an important class of small noncoding RNA molecules that serve as excellent biomarkers of various diseases. However, current miRNA biomarkers, including those comprised of multiple miRNAs, work at a single-miRNA level but not at a miRNA-set level, which is defined as a group of miRNAs sharing common biological characteristics. Given the rapidly accumulating miRNA omics data, we believe that the miRNA-set level analysis could be an important supplement to the single-miRNA level analysis. Therefore, we present sTAM (http://mir.rnanut.net/stam), a computational tool for single-sample miRNA-set enrichment analysis. Moreover, we demonstrate the utility of sTAM scores in discovering miRNA-set level biomarkers through two case studies. We conduct a pan-cancer analysis of the sTAM scores of the "tumor suppressor miRNA set" on 15 types of cancers from The Cancer Genome Atlas (TCGA) and 14 from Gene Expression Omnibus (GEO), results of which indicated a good performance in distinguishing cancers from controls. Moreover, we reveal that the sTAM scores of the "brain development miRNA set" can effectively predict cerebrovascular disorder (CVD). Finally, we believe that sTAM can be used to discover disease-related biomarkers at a miRNA-set level.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.